Authors: Debrix, I Tilleul, P Milleron, B Grene, N Bouleuc, C Roux, D Liote, H Madelaine, I Bellanger, A Conort, O Fontan, JE Le Mercier, F Bardin, C Becker, A

Citation: I. Debrix et al., The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital, CLIN THER, 23(7), 2001, pp. 1116-1127

Authors: Grene, N Pointereau-Bellanger, A Conort, O Fontan, JE Le Mercier, F Madelaine, I Bardin, C Roux, D Debrix, I Tilleul, P

Citation: N. Grene et al., Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors, ANTI-CANC D, 11(2), 2000, pp. 109-115

Authors: Debrix, I Madelaine, I Grenet, N Roux, D Bardin, C Le Mercier, F Fontan, JE Connor, O Pointereau, A Tilleul, P

Citation: I. Debrix et al., Impact of ASCO guidelines for the use of hematopoietic colony stimulating factors (CSFs): survey results of fifteen Paris university hospitals, PHARM WORLD, 21(6), 1999, pp. 270-271

Authors: Debrix, I Combeau, D Stephan, F Benomar, A Becker, A

Citation: I. Debrix et al., Clinical practice guidelines for the use of albumin: results of a drug useevaluation in a Paris hospital, PHARM WORLD, 21(1), 1999, pp. 11-16

Authors: Debrix, I Bouleuc, C Liote, H Milleron, B Beker, A

Citation: I. Debrix et al., Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors, J CL ONCOL, 17(10), 1999, pp. 3360-3361

Authors: Debrix, I Flahault, A Becker, A Schwartz, L Kanfer, A Milleron, B

Citation: I. Debrix et al., Impact of guidelines implemented in a Paris university hospital: application to the use of antiemetics by cancer patients, BR J CL PH, 48(4), 1999, pp. 616-622